Neurogen's P2P Acquisition

Neurogen raised a round of funding on August 18, 2009. Investors include Ligand Pharmaceuticals.

Neurogen is both in the discovery and development of new drug candidates and in the development and integration of new drug-discovery technology, most notably its AIDD (Accelerated Intelligent Drug Di…

Articles about Neurogen's P2P Acquisition: